Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-03-06
2007-03-06
Goldberg, Jeanine A. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
10341550
ABSTRACT:
Methods are provided for the detection of susceptibility to cancer and non-cancerous pathologies in a mammal. Diagnostic kits are also provided.
REFERENCES:
patent: 2003/0092019 (2003-05-01), Meyer et al.
Hirschhorn et al. (Genetics in Medicine. vol. 4, No. 2, pp. 45-61, Mar. 2002).
Ioannidis (Nature Genetics, vol. 29, pp. 306-309, Nov. 2001).
Mayr et al. (Br. Vet. J. vol. 151, pp. 325-329, 1995).
Mayr et al. (Research in Veterinary Science, vol. 68, pp. 63-69 2000).
Mayr, B. “Felis catus tumor suppressor p53 gene, intron 7” Genbank Accession No. U81298, Feb. 1997.
Avigad, S., et al., “A novel germ line p53 mutation in intron 6 in diverse childhood malignancies”,Oncogene, 14(13), (1997), 1541-1545.
Banerji, N., et al., “Alterations in Feline p53 in VAFS”,Genbank Database, Genetic Sequence Listing, Accession No. AF175762, Felis catus p53 gene, intron 7,(Sep. 1999), 1 p.
Birch, J. M., et al., “Relative frequency and morphology of cancers in carriers of germline TP53 mutations,”Oncogene, 20(34), (2001), 4621-4628.
Dewoody, J. A., “Nucleotide Variation in the p53 Tumor-Suppressor Gene of Voles from Chemobyl, Ukraine”,Mutation Research, 439, (1999), 25-36.
Donehower, L. A., “The p53-deficient mouse: a model for basic and applied cancer studies”,Seminars in Cancer Biology, 7(5), (1996), 269-278.
Evans, S. C., et al., “The Li-Fraumeni syndrome: an inherited susceptibility to cancer”,Molecular Medicine Today, 3(9), (1997), 390-395.
Greenblatt, M. S., et al., “Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis”,Cancer Research, 54(18), (1994), 4855-4878.
Kanjilal, S., et al., “High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity”,Cancer Research, 53(13), (1993), 2961-2964.
Kanjilal, S., et al., “p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization”,Cancer Research, 55(16), (1995), 3604-3609.
Khaliq, S., et al., “P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients”,Genetic Testing, 4(1):, (2000), 23-29.
Kuperwasser, C., et al., “Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.”,American Journal of Pathology, 157(6), (2000), 2151-2159.
Malkin, D. et al., “Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms”,Science, 250(4985), (1990), 1233-1238.
Mayr, et al., “Novel p53 tumour suppressor mutations in cases of spindle cell sarcoma, pleomorphic sarcoma and fibrosarcoma in cats”,Veterinary Research Communications, 22, (1998), 249-255.
Mayr, B., et al., “Polymorphisms in feline tumour suppressor gene p53, Mutations in an osteosarcoma and a mammary carcinoma”,Veterinary Journal, 155(1), (1998), 103-106.
Menotti-Raymond, M., et al., “A genetic linkage map of microsatellites in the domestic cat (Felis catus)”,Genomics, 57(1), (1999), 9-23.
Murphy, W. J., et al., “A radiation hybrid map of the cat genome: implications for comparative mapping”,Genome Research, 10(5), (2000), 691-702.
Nambiar, et al., “Mutational Analysis of Tumor Suppressor Gene p53 in feline vaccine Site-Associated Sarcomas”,AJVR, 61, (Oct. 2000), 1277-1281.
O'Brien, S. J., et al., “Comparative gene mapping in the domestic cat (Felis catus)”,Journal of Heredity, 88(5), (1997), 408-414.
O'Brien, S. J., et al., “Comparative genomics: lessons from cats”,Trends in Genetics, 13(10), (1999), 393-399.
O'Brien, S. J., et al., “The promise of comparative genomics in mammals”,Science, 286, (1999),458-462, 479-481.
O'Byrne, K. J., et al., “Chronic immune activation and inflammation as the cause of malignancy”,British Journal of Cancer, 85(4), (2001), 473-483.
Okuda, et al., “Cloning of feline p53 Tumor-Suppressor Gene and its Aberration in Hematopoietic Tumors”,Int. J. Cancer, 58, (1994), 602-607.
Okuda, M., et al., “Molecular cloning and chromosomal mapping of feline p53 tumor suppressor gene”,Journal of Veterinary Medical Science, 55(5), (1993), 801-805.
Srivastava, S., et al., “Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome”,Nature, 348(6303), (1990), 747-749.
Venkatachalam, S., et al., “Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation”,EMBO Journal, 17(16), (1998), 4657-4667.
Verselis, S. J., et al., “Novel p53 splice site mutations in three families with Li-Fraumeni syndrome”,Oncogene, 19(37), (2000), 4230-4235.
Yang, F., et al., “Reciprocal chromosome painting illuminates the history of genome evolution of the domestic cat, dog and human”,Chromosome Research, 8(5), (2000), 393-404.
Nilanjana Banergi & Sagarika Kanjilil, Somatic Alterations of the p53 Tumor Supressor Gene in Vaccine-Associated Feline Sarcoma, AJVR, vol. 67, No. 10, Oct. 2006, pp. 1766-1772.
Andx, Inc.
Brooks & Cameron PLLC
Goldberg Jeanine A.
LandOfFree
Detection of a genetic predisposition to cancers in cats does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of a genetic predisposition to cancers in cats, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of a genetic predisposition to cancers in cats will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3800395